Suspended
The Effectiveness of Intravitreal Avastin Injection for CRVO
What is being collected
Data Collection
Collected from past medical records and data - RetrospectiveWho is being recruted
Cardiovascular Diseases+5
+ Eye Diseases
+ Retinal Diseases
Over 18 Years
+7 Eligibility Criteria
How is the trial designed
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Observational
Study Start: January 2006
Summary
Principal SponsorZiv Hospital
Study ContactJoseph pikkel, M.DMore contacts
Last updated: September 3, 2012Sourced from a government-validated database.Claim as a partner
Study start date: January 1, 2006
Actual date on which the first participant was enrolled.to determine the effectivness of intravitreal avastin injection on visual acuity on people that suffer from central retinal vein occlusion
Principal SponsorZiv Hospital
Study ContactJoseph pikkel, M.DMore contacts
Last updated: September 3, 2012Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
68 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Cardiovascular DiseasesEye DiseasesRetinal DiseasesThrombosisVascular DiseasesEmbolism and ThrombosisVenous ThrombosisRetinal Vein Occlusion
Criteria
3 inclusion criteria required to participate
maximal visual acuity 6/15
patients above 18 years old
suffer from CRVO
4 exclusion criteria prevent from participating
VA of LP
follow up less than 6 months
incomplete medical record
retinal disease other than CRVO
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Recruiting
SuspendedOne Study Center